Annual Interest Expense
$2.06 M
+$1.54 M+294.82%
31 December 2023
Summary:
Verona Pharma annual interest expense is currently $2.06 million, with the most recent change of +$1.54 million (+294.82%) on 31 December 2023. During the last 3 years, it has risen by +$2.02 million (+5777.14%). VRNA annual interest expense is now at all-time high.VRNA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$9.88 M
+$8.13 M+462.44%
30 September 2024
Summary:
Verona Pharma quarterly interest expense is currently $9.88 million, with the most recent change of +$8.13 million (+462.44%) on 30 September 2024. Over the past year, it has increased by +$9.48 million (+2364.34%). VRNA quarterly interest expense is now at all-time high.VRNA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$13.85 M
+$9.48 M+217.11%
30 September 2024
Summary:
Verona Pharma TTM interest expense is currently $13.85 million, with the most recent change of +$9.48 million (+217.11%) on 30 September 2024. Over the past year, it has increased by +$12.18 million (+732.21%). VRNA TTM interest expense is now at all-time high.VRNA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +294.8% | +2364.3% | +732.2% |
| 3 y3 years | +5777.1% | +10000.0% | +4675.2% |
| 5 y5 years | +1429.4% | +10000.0% | +7559.3% |
VRNA Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +5777.1% | at high | >+9999.0% | at high | +4675.2% |
| 5 y | 5 years | at high | at high | +6732.2% | at high | +9394.0% | |
| alltime | all time | at high | at high | +1075.1% | at high | +1592.9% |
Verona Pharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.88 M(+462.4%) | $13.85 M(+217.1%) |
| June 2024 | - | $1.76 M(+10.8%) | $4.37 M(+30.4%) |
| Mar 2024 | - | $1.59 M(+154.6%) | $3.35 M(+62.9%) |
| Dec 2023 | $2.06 M(+294.8%) | $623.00 K(+55.4%) | $2.06 M(+23.6%) |
| Sept 2023 | - | $401.00 K(-45.8%) | $1.66 M(+20.7%) |
| June 2023 | - | $740.00 K(+152.6%) | $1.38 M(+88.9%) |
| Mar 2023 | - | $293.00 K(+27.4%) | $730.00 K(+40.1%) |
| Dec 2022 | $521.00 K(+53.2%) | $230.00 K(+98.3%) | $521.00 K(+38.6%) |
| Sept 2022 | - | $116.00 K(+27.5%) | $376.00 K(+8.7%) |
| June 2022 | - | $91.00 K(+8.3%) | $346.00 K(+1.8%) |
| Mar 2022 | - | $84.00 K(-1.2%) | $340.00 K(0.0%) |
| Dec 2021 | $340.00 K(+871.4%) | $85.00 K(-1.2%) | $340.00 K(+17.2%) |
| Sept 2021 | - | $86.00 K(+1.2%) | $290.00 K(+42.2%) |
| June 2021 | - | $85.00 K(+1.2%) | $204.00 K(+71.4%) |
| Mar 2021 | - | $84.00 K(+140.0%) | $119.00 K(+240.0%) |
| Dec 2020 | $35.00 K | $35.00 K(>+9900.0%) | $35.00 K(-123.5%) |
| Sept 2020 | - | $0.00(0.0%) | -$149.00 K(+56.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $0.00(0.0%) | -$95.00 K(+92.3%) |
| Mar 2020 | - | $0.00(-100.0%) | -$49.40 K(+4390.9%) |
| Dec 2019 | $0.00(-100.0%) | -$149.00 K(-375.9%) | -$1100.00(-100.6%) |
| Sept 2019 | - | $54.00 K(+18.4%) | $180.80 K(+11.6%) |
| June 2019 | - | $45.60 K(-5.6%) | $162.00 K(+6.8%) |
| Mar 2019 | - | $48.30 K(+46.8%) | $151.70 K(+21.9%) |
| Dec 2018 | $134.50 K(+36.3%) | $32.90 K(-6.5%) | $124.40 K(+29.0%) |
| Sept 2018 | - | $35.20 K(-0.3%) | $96.40 K(+3.2%) |
| June 2018 | - | $35.30 K(+68.1%) | $93.40 K(+6.1%) |
| Mar 2018 | - | $21.00 K(+328.6%) | $88.00 K(-3.0%) |
| Dec 2017 | $98.70 K(-7.0%) | $4900.00(-84.8%) | $90.70 K(-109.8%) |
| Sept 2017 | - | $32.20 K(+7.7%) | -$927.60 K(+2710.9%) |
| June 2017 | - | $29.90 K(+26.2%) | -$33.00 K(-0.3%) |
| Mar 2017 | - | $23.70 K(-102.3%) | -$33.10 K(-41.7%) |
| Dec 2016 | $106.10 K(+13.7%) | -$1.01 M(-209.3%) | -$56.80 K(-105.9%) |
| Sept 2016 | - | $926.80 K(+3010.1%) | $956.60 K(+3110.1%) |
| June 2016 | - | $29.80 K | $29.80 K |
| Dec 2015 | $93.30 K | - | - |
FAQ
- What is Verona Pharma annual interest expense?
- What is the all time high annual interest expense for Verona Pharma?
- What is Verona Pharma annual interest expense year-on-year change?
- What is Verona Pharma quarterly interest expense?
- What is the all time high quarterly interest expense for Verona Pharma?
- What is Verona Pharma quarterly interest expense year-on-year change?
- What is Verona Pharma TTM interest expense?
- What is the all time high TTM interest expense for Verona Pharma?
- What is Verona Pharma TTM interest expense year-on-year change?
What is Verona Pharma annual interest expense?
The current annual interest expense of VRNA is $2.06 M
What is the all time high annual interest expense for Verona Pharma?
Verona Pharma all-time high annual interest expense is $2.06 M
What is Verona Pharma annual interest expense year-on-year change?
Over the past year, VRNA annual interest expense has changed by +$1.54 M (+294.82%)
What is Verona Pharma quarterly interest expense?
The current quarterly interest expense of VRNA is $9.88 M
What is the all time high quarterly interest expense for Verona Pharma?
Verona Pharma all-time high quarterly interest expense is $9.88 M
What is Verona Pharma quarterly interest expense year-on-year change?
Over the past year, VRNA quarterly interest expense has changed by +$9.48 M (+2364.34%)
What is Verona Pharma TTM interest expense?
The current TTM interest expense of VRNA is $13.85 M
What is the all time high TTM interest expense for Verona Pharma?
Verona Pharma all-time high TTM interest expense is $13.85 M
What is Verona Pharma TTM interest expense year-on-year change?
Over the past year, VRNA TTM interest expense has changed by +$12.18 M (+732.21%)